Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 30.83M P/E - EPS this Y 4.90% Ern Qtrly Grth -
Income -32.33M Forward P/E -1.01 EPS next Y 23.10% 50D Avg Chg -13.00%
Sales - PEG 0.02 EPS past 5Y - 200D Avg Chg -40.00%
Dividend N/A Price/Book 0.25 EPS next 5Y -65.60% 52W High Chg -65.00%
Recommedations 1.70 Quick Ratio 13.88 Shares Outstanding 39.66M 52W Low Chg 10.00%
Insider Own 0.07% ROA -25.80% Shares Float 28.89M Beta 0.89
Inst Own 46.06% ROE -70.71% Shares Shorted/Prior 83.33K/100.69K Price 1.37
Gross Margin - Profit Margin - Avg. Volume 137,261 Target Price 14.00
Oper. Margin - Earnings Date Nov 7 Volume 100,990 Change 5.38%
About Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company uses its immunology expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for kidney transplantation, xenotransplantation, and liver transplantation. The company has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.

Eledon Pharmaceuticals, Inc. News
11/14/24 Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) market cap dropped US$48m last week; individual investors who hold 57% were hit as were institutions
11/12/24 Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
11/06/24 Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
10/29/24 Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
10/29/24 Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
09/11/24 Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference
09/04/24 Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients
08/14/24 Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results
07/29/24 Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection
07/02/24 Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
06/03/24 Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
05/09/24 Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
05/09/24 Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
05/07/24 Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
05/07/24 Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
03/28/24 Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
03/25/24 Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
03/21/24 Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
02/13/24 Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/04/24 Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
ELDN Chatroom

User Image sauerbach123 Posted - 9 hours ago

$ELDN Anyone notice who the new commissioner of the FDA will be? An Islet Transplant surgeon!!! $SNY $AMGEN https://www.nbcnews.com/health/health-news/trump-picks-dr-marty-makary-johns-hopkins-surgeon-fda-chief-rcna180883

User Image Interplanetary_Gary Posted - 17 hours ago

$ABVE If you follow the sectors at all you should have surmised high-tech farming is positioned to overtake bio-tech as the leading quality-of-life industry sector. Now is the time to get ahead of the convergence. Diversifying your port by combining $ABVE with something like $ELDN (timed for optimal entry such as right after the recent offering) or $QNTM (time it for the weeks preceeding study results, such as the recent announcement that the dosing study was set to proceed). Stocks don't create millionaires. Proactivity and insight do.

User Image Stocks4thought Posted - 1 day ago

$ELDN I was crying I didn't own enough at $5.50 and got most of my cargo at $3 sub..............

User Image Stocks4thought Posted - 1 day ago

$ELDN $4.18 and she stops hooking on the golf course$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$ $SLNO $ALT $VKTX

User Image 7Billiards Posted - 1 day ago

$ELDN could use some more photos of lines on charts on this board

User Image 7Billiards Posted - 1 day ago

$ELDN I’m in, let’s cure these diabetics

User Image Stocks4thought Posted - 3 days ago

$ELDN Should Scoot soon .50 cent move (no relation to the rapper).............................ot $SLNO $ALT $BWAY $VYGR

User Image Jennie_G Posted - 3 days ago

$ABVE High-tech farming is intersecting with and will overtake bio-tech as the leading industry sector for quality of life! Now is the time to get ahead of the convergence. Diversifying your port by combining $ABVE with something like $ELDN (timed for optimal entry such as right after the recent offering) or $QNTM (time it for the weeks preceeding study results, such as the recent announcement that the dosing study was set to proceed). Proactivity and insight create millionaires. So exciting!

User Image bilocelhi Posted - 4 days ago

$ELDN looks like a king downtrend up to the next catalyst, looking for low $2s

User Image 7Billiards Posted - 1 week ago

$ELDN anyone have some DD? Type 1 diabetic here would love if this is true

User Image Stocks4thought Posted - 1 week ago

$ELDN $5 next week then $7 cure for T1d ot $SLNO $VKTX $ALT $BWAY

User Image Stocks4thought Posted - 1 week ago

$ELDN MYNZ is a piece of shit. Nothing there- mafia stock. spammer below.

User Image Stocks4thought Posted - 1 week ago

$ELDN Listen and forget the price action https://wsw.com/webcast/guggen/eldn/1925783

User Image jshlam Posted - 1 week ago

$ELDN brutal move on no volume

User Image jshlam Posted - 2 weeks ago

$ELDN completed cured type 1 diabetes? https://www.dailymail.co.uk/health/article-14015591/illinois-woman-cured-type-1-diabetes-pioneering-therapy.html

User Image Ontherag Posted - 2 weeks ago

$ELDN

User Image jshlam Posted - 2 weeks ago

$ELDN hmm

User Image Marlala Posted - 2 weeks ago

$ELDN inverse head and shoulders on the weekly

User Image BriOnH Posted - 2 weeks ago

@NorthstarT1D bought a starter in $ELDN with 250 shares. Worth checking out I think. More interested in it for other transplants than islets, but could be a good stop gap for islets, until immunosuppression isn't needed. https://www.dailymail.co.uk/health/article-14015591/illinois-woman-cured-type-1-diabetes-pioneering-therapy.html

User Image Marlala Posted - 2 weeks ago

$ELDN breakout imminent 🚀🚀🚀

User Image Ontherag Posted - 2 weeks ago

$ELDN We got a functional cure for T1D

User Image RallyRaider Posted - 2 weeks ago

$ELDN run free

User Image Marlala Posted - 2 weeks ago

$ELDN

User Image Ontherag Posted - 2 weeks ago

$ELDN

User Image hivali Posted - 2 weeks ago

$ELDN Why isn’t numbers moving , it’s a $5.00

User Image RallyRaider Posted - 2 weeks ago

$ELDN someone messing with the price discovery

User Image jshlam Posted - 2 weeks ago

$ELDN Hmm

User Image RallyRaider Posted - 2 weeks ago

$ELDN here it comes

User Image Behindthelight Posted - 2 weeks ago

$ELDN damn yesterday was the time to buy. Current valuation is a joke and a gift

User Image FastTrack2Wealth Posted - 2 weeks ago

🚨 MYNZ HUGE PR drop incoming before the Nov 13 meeting 🔥 Someone is pushing these dates of upcoming NEWS 3 biggest stock alert channels announced, might consider to add now, who knows. $GNFT $AVIR $VNDA $ELDN

Analyst Ratings
HC Wainwright & Co. Buy Jun 4, 24
HC Wainwright & Co. Buy May 10, 24
HC Wainwright & Co. Buy May 7, 24
HC Wainwright & Co. Buy Mar 22, 24
HC Wainwright & Co. Buy Nov 13, 23
HC Wainwright & Co. Buy Oct 24, 23
Noble Capital Markets Outperform Sep 27, 23
Cantor Fitzgerald Overweight Aug 22, 23
HC Wainwright & Co. Buy May 26, 23